Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Intervention1: Tab Ethinyl Estradiol 35 mcg with Cyproterone acetate 2mg once a day after meal: Tab Ethinyl Estradiol 35 mcg with Cyproterone acetate 2mg will be given for 6 months
Control Interventio
Sponsors
All India Institute Of Medical Sciences Bilaspur
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with PCOS according to modified Rotterdam 2003 Criteria 2.Females of age between18- 45 years.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring the change in mean inflammatory markers and adipokines level from baseline to 24 weeks in the metformin group as compared to OCPs groupTimepoint: Measuring the change in mean inflammatory markers and adipokines level from baseline to 24 weeks in the metformin group as compared to OCPs group | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Mean change from baseline in insulin resistance, BMI and lipid profile at 24 weeks of treatment and also among two groups. 2.Mean change from the baseline in gonadotropins, total testosterone and free testosterone index levels at 24 weeks of treatment and also among the two groups. Timepoint: 24 weeks | — |
Countries
India
Contacts
Public ContactDr Preyander Singh Thakur
All India Institute of Medical sciences,Bilaspur (Himachal Pradesh)
Outcome results
None listed